Characterization of Intestinal Microbiota in Children With Inborn Errors of Metabolism (IEM)
NCT ID: NCT05330039
Last Updated: 2024-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2021-11-30
2024-02-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism
NCT04248062
Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy
NCT04109352
MSOT and MRI for Non-invasive Assessment of Intestinal Transit Time in Children With Chronic Bowel Emptying Disorders
NCT06911749
Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications
NCT02699320
Infant Sleep Behaviour and Gut Microbacteria
NCT02836119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main focus of the study is to assess the contribution of the intestinal microbiota to disease severity in children that suffer from different forms of IEM and potentially find microbiota targets that could be used in the design of therapeutic/prophylactic agents.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with IEM
Collection of biological samples (stool and urine) and health-related data at two timepoints, three to six months apart.
No interventions assigned to this group
Healthy Siblings
Collection of biological samples (stool) and health-related data at two timepoints, three to six months apart.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* use of an investigational drug or device less than 30 days prior to the study, or current enrollment in another investigational drug or device study less than 30 days prior to the study
* considered to be poor attendees or unlikely for any reason to be able to comply with the study procedures, in the opinion of the investigator
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Children's Hospital
OTHER
Emma Marie Caroline Slack
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emma Marie Caroline Slack
Prof. Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Children's Hospital
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IEM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.